biomedicina slovenica


pr=Binder : 21

  1. Sanchez Olivier; Charles-Nelson Anais; Ageno Walter; Barco Stefano; Binder Harald; Chatellier Gilles; Duerschmied Daniel; Empen Klaus; Ferreira Melanie; Girard Philippe; Kozak Matija
    Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism
    2022
  2. Klok Frederikus A.; Ageno Walter; Barco Stefano; Binder Harald; Brenner Benjamin; Duerschmied Daniel; Empen Klaus; Faggiano Pompilio; Ficker Joachim H.; Kozak Matija
    Dabigatran after short heparin anticoagulation for acute intermediate-risk pulmonary embolism
    2017
  3. Andreoli Laura; Nalli Cecilia; Motta M.; Norman Gary L.; Shums Zakera; Encabo Susan; Binder Walter L; Nuzzo Monica; Frassi M.; Lojacono A.; Avčin Tadej; Meroni PierLuigi; Tincani A.
    Anti-[beta]2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5
    2011
  4. Hoemberg V; Binder H
    Book of abstracts of the 6th World congress for neurorehabilitation; 2010 Mar 21-25; Vienna
    2010
  5. Mahler Michel; Radice Antonella; Sinico Renato A; Damoiseaux Jan; Seaman Andrea; Buckmelter Kristen; Vizjak Alenka; Buchner Carol; Binder Walter L; Fritzler Marvin J
    Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study
    2012
  6. Andreoli L; Nalli C; Motta M; Norman GL; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avčin T; Meroni PL
    Sottopopolazioni di anticorpi anti-beta2glicoproteina I con diverso potenziale patogenetico: fine specificita` nei confronti dei domini della beta2glicoproteina I
    [Subpopulations of anti-beta2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of beta2glycoprotein I]
    2010
  7. Nalli C; Andreoli L; Motta M; Norman GL; Shums Z; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avčin T
    La fine specificita degli anticorpi anti-beta2 glicoproteina I nelle malattie autoimmuni sistemiche e prevalentemente diretta verso il dominio 1
    [Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1]
    2011
  8. Jilge B; Minassian K; Rattay F; Pinter MM; Gerstenbrand F; Binder H; Dimitrijević MR
    Initiating extension of the lower limbs in subjects with complete spinal cord injury by epidural lumbar cord stimulation
    2004
  9. Argenziano Giuseppe; Soyer Peter; Chimenti Sergio; Talamini Renato; Corona Rosamaria; Sera Francesco; Binder Michael; Cerroni Lorenzo; de Rosa Gaetano; Bartenjev Igor
    Dermoscopy of pigmented skin lesions: results of a consensus meeting via the internet
    2003
  10. Stegnar M; Uhrin P; Peternel P; Mavri A; Zeyda M; Salobir-Pajnič B; Binder BR
    Association of the 4G/5G polymorphism and metabolic factors to plasma plasminogen activator inhibitor 1 levels in deep vein thrombosis
    1997
  11. Stegnar M; Uhrin P; Peternel P; Mavri A; Zeyda M; Salobir-Pajnič B; Binder BR
    Of the plasminogen activator inhibitor-1 gene and its plasma levels in deep vein thrombosis
    1997
  12. Peternel P; Cvelbar-Marinko T; Goršič-Tomažič K; Stegnar M; Salobir-Pajnič B; Uhrin P; Binder BR
    Activated protein C resistance among patients with deep vein thrombosis in Slovenia
    1996
  13. Murg M; Binder H; Dimitrijević MR
    Epidural electric stimulation of posterior structures of the human lumbar spinal cord: 1. muscle twitches - a functional method to define the site of stimulation
    2000
  14. Minassian K; Jilge B; Rattay F; Pinter MM; Gerstenbrand F; Binder H; Dimitrijević MR
    Effective spinal cord stimulation (SCS) for evoking stepping movement of paralyzed lower limbs: study of posterior root muscle reflex responses
    2002
  15. Weiss T; Macfelda K; Kaun C; Zorn G; Kapeller B; Springer C; Bialy J; Losert UM; Breuss JM; Binder BR
    Inflammatory cytokines and growth factors regulate plasminogen activator inhibitor-1 (PAI-1) in human adult cardiac myocytes (HACM)
    2001
  16. Niessner A; Hornykewycz S; Joerg M; Zorn G; Graf S; Binder BR; Huber K
    Increased risk of restenosis after successful percutaneous transluminal coronary angioplasty in patients with permanently elevated anticardiolipin antibodies
    2001
  17. Binder BR
    Arterial thrombosis. Pathomechanism, prediction and therapy
    2001
  18. Mavri Alenka; Stegnar Mojca; Krebs Michael; Sentočnik Jožica T; Greiger Margarethe; Binder Bernard R
    Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
    1999
  19. Stegnar Mojca; Uhrin Pavel; Peternel Polona; Mavri Alenka; Salobir-Pajnič Barbara; Stare Janez; Binder Bernd R
    The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism
    1998
  20. Stegnar M; Peternel P; Uhrin P; Cvelbar-Marinko T; Goršič-Tomažič K; Binder BR
    Fibrinolysis in patients with the 1691 G-A mutation in factor V gene and history of deep vein thrombosis
    1997
  21. Grubič Nelly; Stegnar Mojca; Peternel Polona; Kaider Alexandra; Binder Bernd R
    A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis
    1996


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics